Rubius Therapeutics

-$0.11 (-0.73%) As of 1:45 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RUBY and other ETFs, options, and stocks.

About RUBY

Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines for cancer, autoimmune diseases, hemophilia, and infectious and metabolic diseases. The company was founded by Avak Kahvejian, Jordi Mata-Fink, and Noubar Afeyan on April 26, 2013 and is headquartered in Cambridge, MA.

CEO

Pablo J. Cagnoni

Employees

204

Headquarters

Cambridge, Massachusetts

Founded

2013

RUBY Key Statistics

Market Cap

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

236.38K

High Today

$14.50

Low Today

$14.25

Open Price

$14.43

Volume

6.06K

52 Week High

$38.71

52 Week Low

$4.20

RUBY News

Simply Wall St44m

Are Rubius Therapeutics, Inc. Investors Paying Above The Intrinsic Value?

Today we will run through one way of estimating the intrinsic value of Rubius Therapeutics, Inc. ( ) by taking the expected future cash flows and discounting th

Analyst Ratings

50%

of 6 ratings

Buy

50%

Hold

50%

Sell

RUBY Earnings

-$0.60

-$0.40

-$0.20

$0.00

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Estimated

— per share

Actual

Expected Nov 8, Pre-Market